APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologic and Medical Imaging Reagents

Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.

Selected research

Market Analysis & Forecast

Global Biologic and Medical Imaging Reagents Market Analysis and Forecast 2026-2032

28 December 2025198 pages

Choose your research edition.

Industry ResearchBiologic and Medical Imaging Reagents Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologic and Medical Imaging Reagents Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Biologic and Medical Imaging Reagents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologic and Medical Imaging Reagents Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologic and Medical Imaging Reagents Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.

The global well-known brands in Biologic and Medical Imaging Reagents include Cardinal Health(6.77%), Bracco(5.41%), Bayer HealthCare(3.48%), Curium Pharma(2.02%), Hengrui Medicine(2.67%), GE Healthcare(2.53%), Lantheus Medical Imaging(2.01%), Novartis (AAA)(2.77%), Thermo Fisher Scientific(2.16%), Jubilant DraxImage(1.63%), PerkinElmer(1.44%), Guerbet(1.75%), Nihon Medi-Physics(1.75%), YRPG(1.09%) and Others(62.52%).

The application area of Biologic and Medical Imaging Reagents include Hospitals, Clinics and Other.

Read the full market overview

In terms of types, Biologic and Medical Imaging Reagents can be divided into Nuclear Imaging (PET & SPECT) Reagents, Magnetic Resonance Imaging (MRI) Reagents, Fluorescence Imaging Reagents, Ultrasound and X-ray Contrast Reagents and Other.

On basis of geography, Biologic and Medical Imaging Reagents are manufactured in North America, Europe, China and Japan.

Report Includes

This report presents an overview of global market for Biologic and Medical Imaging Reagents, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biologic and Medical Imaging Reagents, also provides the revenue of main regions and countries. Of the upcoming market potential for Biologic and Medical Imaging Reagents, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biologic and Medical Imaging Reagents revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biologic and Medical Imaging Reagents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biologic and Medical Imaging Reagents revenue, projected growth trends, production technology, application and end-user industry.

Biologic and Medical Imaging Reagents Segment by Company

Cardinal Health

Bracco

Bayer HealthCare

Curium Pharma

Hengrui Medicine

GE Healthcare

Lantheus Medical Imaging

Novartis (AAA)

Thermo Fisher Scientific

Jubilant DraxImage

PerkinElmer

Guerbet

Nihon Medi-Physics

YRPG

Biologic and Medical Imaging Reagents Segment by Type

Nuclear Imaging (PET & SPECT) Reagents

Magnetic Resonance Imaging (MRI) Reagents

Fluorescence Imaging Reagents

Ultrasound and X-ray Contrast Reagents

Other

Biologic and Medical Imaging Reagents Segment by Application

Hospitals

Clinics

Other

Biologic and Medical Imaging Reagents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic and Medical Imaging Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologic and Medical Imaging Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic and Medical Imaging Reagents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biologic and Medical Imaging Reagents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biologic and Medical Imaging Reagents company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologic and Medical Imaging Reagents revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biologic and Medical Imaging Reagents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Nuclear Imaging (PET & SPECT) Reagents Major Player Table 3. Magnetic Resonance Imaging (MRI) Reagents Major Player Table 4. Fluorescence Imaging Reagents Major Player Table 5. Ultrasound and X-ray Contrast Reagents Major Player Table 6. Other Major Player Table 7. Global Biologic and Medical Imaging Reagents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospitals Major Player Table 9. Clinics Major Player Table 10. Other Major Player Table 11. Biologic and Medical Imaging Reagents Industry Trends Table 12. Biologic and Medical Imaging Reagents Industry Drivers Table 13. Biologic and Medical Imaging Reagents Industry Opportunities and Challenges Table 14. Biologic and Medical Imaging Reagents Industry Restraints Table 15. Global Biologic and Medical Imaging Reagents Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Biologic and Medical Imaging Reagents Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Biologic and Medical Imaging Reagents Market Share by Region (2021-2026) Table 18. Global Biologic and Medical Imaging Reagents Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Biologic and Medical Imaging Reagents Market Share by Region (2027-2032) Table 20. Global Biologic and Medical Imaging Reagents Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Biologic and Medical Imaging Reagents Revenue Market Share by Players (2021-2026) Table 22. Global Biologic and Medical Imaging Reagents Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Biologic and Medical Imaging Reagents Key Players Headquarters & Area Served Table 24. Global Biologic and Medical Imaging Reagents Players, Product Type & Application Table 25. Global Biologic and Medical Imaging Reagents Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Biologic and Medical Imaging Reagents by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Biologic and Medical Imaging Reagents Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Biologic and Medical Imaging Reagents Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Biologic and Medical Imaging Reagents Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Biologic and Medical Imaging Reagents Revenue Market Share by Type (2021-2026) Table 32. Global Biologic and Medical Imaging Reagents Revenue Market Share by Type (2027-2032) Table 33. Global Biologic and Medical Imaging Reagents Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Biologic and Medical Imaging Reagents Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Biologic and Medical Imaging Reagents Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Biologic and Medical Imaging Reagents Revenue Market Share by Application (2021-2026) Table 37. Global Biologic and Medical Imaging Reagents Revenue Market Share by Application (2027-2032) Table 38. Cardinal Health Company Information Table 39. Cardinal Health Business Overview Table 40. Cardinal Health Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Cardinal Health Biologic and Medical Imaging Reagents Product Portfolio Table 42. Cardinal Health Recent Development Table 43. Bracco Company Information Table 44. Bracco Business Overview Table 45. Bracco Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Bracco Biologic and Medical Imaging Reagents Product Portfolio Table 47. Bracco Recent Development Table 48. Bayer HealthCare Company Information Table 49. Bayer HealthCare Business Overview Table 50. Bayer HealthCare Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Bayer HealthCare Biologic and Medical Imaging Reagents Product Portfolio Table 52. Bayer HealthCare Recent Development Table 53. Curium Pharma Company Information Table 54. Curium Pharma Business Overview Table 55. Curium Pharma Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Curium Pharma Biologic and Medical Imaging Reagents Product Portfolio Table 57. Curium Pharma Recent Development Table 58. Hengrui Medicine Company Information Table 59. Hengrui Medicine Business Overview Table 60. Hengrui Medicine Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Hengrui Medicine Biologic and Medical Imaging Reagents Product Portfolio Table 62. Hengrui Medicine Recent Development Table 63. GE Healthcare Company Information Table 64. GE Healthcare Business Overview Table 65. GE Healthcare Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. GE Healthcare Biologic and Medical Imaging Reagents Product Portfolio Table 67. GE Healthcare Recent Development Table 68. Lantheus Medical Imaging Company Information Table 69. Lantheus Medical Imaging Business Overview Table 70. Lantheus Medical Imaging Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Lantheus Medical Imaging Biologic and Medical Imaging Reagents Product Portfolio Table 72. Lantheus Medical Imaging Recent Development Table 73. Novartis (AAA) Company Information Table 74. Novartis (AAA) Business Overview Table 75. Novartis (AAA) Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Novartis (AAA) Biologic and Medical Imaging Reagents Product Portfolio Table 77. Novartis (AAA) Recent Development Table 78. Thermo Fisher Scientific Company Information Table 79. Thermo Fisher Scientific Business Overview Table 80. Thermo Fisher Scientific Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Thermo Fisher Scientific Biologic and Medical Imaging Reagents Product Portfolio Table 82. Thermo Fisher Scientific Recent Development Table 83. Jubilant DraxImage Company Information Table 84. Jubilant DraxImage Business Overview Table 85. Jubilant DraxImage Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Jubilant DraxImage Biologic and Medical Imaging Reagents Product Portfolio Table 87. Jubilant DraxImage Recent Development Table 88. PerkinElmer Company Information Table 89. PerkinElmer Business Overview Table 90. PerkinElmer Biologic and Medical Imaging Reagents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. PerkinElmer Biologic and Medical Imaging Reagents Product Portfolio Table 92. PerkinElmer Recent Development Table 93. Guerbet Company Information Table 94. Guerbet Business Overview Table 95. Guerbet Biologic and Medical Imaging Reagents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Guerbet Biologic and Medical Imaging Reagents Product Portfolio Table 97. Guerbet Recent Development Table 98. Nihon Medi-Physics Company Information Table 99. Nihon Medi-Physics Business Overview Table 100. Nihon Medi-Physics Biologic and Medical Imaging Reagents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Nihon Medi-Physics Biologic and Medical Imaging Reagents Product Portfolio Table 102. Nihon Medi-Physics Recent Development Table 103. YRPG Company Information Table 104. YRPG Business Overview Table 105. YRPG Biologic and Medical Imaging Reagents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. YRPG Biologic and Medical Imaging Reagents Product Portfolio Table 107. YRPG Recent Development Table 108. North America Biologic and Medical Imaging Reagents Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Biologic and Medical Imaging Reagents Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Biologic and Medical Imaging Reagents Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Biologic and Medical Imaging Reagents Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Biologic and Medical Imaging Reagents Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. North America Biologic and Medical Imaging Reagents Revenue by Country (2021-2026) & (US$ Million) Table 114. North America Biologic and Medical Imaging Reagents Revenue by Country (US$ Million) & (2027-2032) Table 115. Europe Biologic and Medical Imaging Reagents Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Biologic and Medical Imaging Reagents Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Biologic and Medical Imaging Reagents Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Biologic and Medical Imaging Reagents Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Biologic and Medical Imaging Reagents Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe Biologic and Medical Imaging Reagents Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Biologic and Medical Imaging Reagents Revenue by Country (US$ Million) & (2027-2032) Table 122. China Biologic and Medical Imaging Reagents Revenue by Type (2021-2026) & (US$ Million) Table 123. China Biologic and Medical Imaging Reagents Revenue by Type (2027-2032) & (US$ Million) Table 124. China Biologic and Medical Imaging Reagents Revenue by Application (2021-2026) & (US$ Million) Table 125. China Biologic and Medical Imaging Reagents Revenue by Application (2027-2032) & (US$ Million) Table 126. Asia Biologic and Medical Imaging Reagents Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Biologic and Medical Imaging Reagents Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Biologic and Medical Imaging Reagents Revenue by Application (2021-2026) & (US$ Million) Table 129. Asia Biologic and Medical Imaging Reagents Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Biologic and Medical Imaging Reagents Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Asia Biologic and Medical Imaging Reagents Revenue by Region (US$ Million) & (2021-2026) Table 132. Asia Biologic and Medical Imaging Reagents Revenue by Region (US$ Million) & (2027-2032) Table 133. SAMEA Biologic and Medical Imaging Reagents Revenue by Type (2021-2026) & (US$ Million) Table 134. SAMEA Biologic and Medical Imaging Reagents Revenue by Type (2027-2032) & (US$ Million) Table 135. SAMEA Biologic and Medical Imaging Reagents Revenue by Application (2021-2026) & (US$ Million) Table 136. SAMEA Biologic and Medical Imaging Reagents Revenue by Application (2027-2032) & (US$ Million) Table 137. SAMEA Biologic and Medical Imaging Reagents Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. SAMEA Biologic and Medical Imaging Reagents Revenue by Country (2021-2026) & (US$ Million) Table 139. SAMEA Biologic and Medical Imaging Reagents Revenue by Country (US$ Million) & (2027-2032) Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Biologic and Medical Imaging Reagents Image Figure 2. Global Biologic and Medical Imaging Reagents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologic and Medical Imaging Reagents Market Size Share 2021 VS 2025 VS 2032 Figure 4. Nuclear Imaging (PET & SPECT) Reagents Image Figure 5. Magnetic Resonance Imaging (MRI) Reagents Image Figure 6. Fluorescence Imaging Reagents Image Figure 7. Ultrasound and X-ray Contrast Reagents Image Figure 8. Other Image Figure 9. Global Biologic and Medical Imaging Reagents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Biologic and Medical Imaging Reagents Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospitals Image Figure 12. Clinics Image Figure 13. Other Image Figure 14. Global Biologic and Medical Imaging Reagents Market Size (US$ Million) & (2021-2032) Figure 15. Global Biologic and Medical Imaging Reagents Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Biologic and Medical Imaging Reagents Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Biologic and Medical Imaging Reagents Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Biologic and Medical Imaging Reagents Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Biologic and Medical Imaging Reagents Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Biologic and Medical Imaging Reagents Revenue Market Share by Type (2021-2032) Figure 22. Global Biologic and Medical Imaging Reagents Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Biologic and Medical Imaging Reagents Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Biologic and Medical Imaging Reagents Revenue Market Share by Application (2021-2032) Figure 25. North America Biologic and Medical Imaging Reagents Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Biologic and Medical Imaging Reagents Revenue Share by Type (2021-2032) Figure 27. North America Biologic and Medical Imaging Reagents Revenue Share by Application (2021-2032) Figure 28. North America Biologic and Medical Imaging Reagents Revenue Share by Country (2021-2032) Figure 29. United States Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Biologic and Medical Imaging Reagents Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Biologic and Medical Imaging Reagents Revenue Share by Type (2021-2032) Figure 34. Europe Biologic and Medical Imaging Reagents Revenue Share by Application (2021-2032) Figure 35. Europe Biologic and Medical Imaging Reagents Revenue Share by Country (2021-2032) Figure 36. Germany Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Biologic and Medical Imaging Reagents Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Biologic and Medical Imaging Reagents Revenue Share by Type (2021-2032) Figure 46. China Biologic and Medical Imaging Reagents Revenue Share by Application (2021-2032) Figure 47. Asia Biologic and Medical Imaging Reagents Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Biologic and Medical Imaging Reagents Revenue Share by Type (2021-2032) Figure 49. Asia Biologic and Medical Imaging Reagents Revenue Share by Application (2021-2032) Figure 50. Asia Biologic and Medical Imaging Reagents Revenue Share by Region (2021-2032) Figure 51. Japan Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Biologic and Medical Imaging Reagents Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Biologic and Medical Imaging Reagents Revenue Share by Type (2021-2032) Figure 59. SAMEA Biologic and Medical Imaging Reagents Revenue Share by Application (2021-2032) Figure 60. SAMEA Biologic and Medical Imaging Reagents Revenue Share by Country (2021-2032) Figure 61. Brazil Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Nuclear Imaging (PET & SPECT) Reagents
  • Magnetic Resonance Imaging (MRI) Reagents
  • Fluorescence Imaging Reagents
  • Ultrasound and X-ray Contrast Reagents
  • Other
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Cardinal Health
  • Bracco
  • Bayer HealthCare
  • Curium Pharma
  • Hengrui Medicine
  • GE Healthcare
  • Lantheus Medical Imaging
  • Novartis (AAA)
  • Thermo Fisher Scientific
  • Jubilant DraxImage
  • PerkinElmer
  • Guerbet
  • Nihon Medi-Physics
  • YRPG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biologic and Medical Imaging Reagents Market by Type
  3. 1.2.1 Global Biologic and Medical Imaging Reagents Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Nuclear Imaging (PET & SPECT) Reagents
  5. 1.2.3 Magnetic Resonance Imaging (MRI) Reagents
  6. 1.2.4 Fluorescence Imaging Reagents
  7. 1.2.5 Ultrasound and X-ray Contrast Reagents
  8. 1.2.6 Other
  9. 1.3 Biologic and Medical Imaging Reagents Market by Application
  10. 1.3.1 Global Biologic and Medical Imaging Reagents Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals
  12. 1.3.3 Clinics
  13. 1.3.4 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Biologic and Medical Imaging Reagents Market Dynamics
  1. 2.1 Biologic and Medical Imaging Reagents Industry Trends
  2. 2.2 Biologic and Medical Imaging Reagents Industry Drivers
  3. 2.3 Biologic and Medical Imaging Reagents Industry Opportunities and Challenges
  4. 2.4 Biologic and Medical Imaging Reagents Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biologic and Medical Imaging Reagents Market Perspective (2021-2032)
  2. 3.2 Global Biologic and Medical Imaging Reagents Growth Trends by Region
  3. 3.2.1 Global Biologic and Medical Imaging Reagents Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biologic and Medical Imaging Reagents Market Size by Region (2021-2026)
  5. 3.2.3 Global Biologic and Medical Imaging Reagents Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biologic and Medical Imaging Reagents Revenue by Players
  2. 4.1.1 Global Biologic and Medical Imaging Reagents Revenue by Players (2021-2026)
  3. 4.1.2 Global Biologic and Medical Imaging Reagents Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biologic and Medical Imaging Reagents Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biologic and Medical Imaging Reagents Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biologic and Medical Imaging Reagents Key Players Headquarters & Area Served
  7. 4.4 Global Biologic and Medical Imaging Reagents Players, Product Type & Application
  8. 4.5 Global Biologic and Medical Imaging Reagents Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biologic and Medical Imaging Reagents Market CR5 and HHI
  11. 4.6.3 2025 Biologic and Medical Imaging Reagents Tier 1, Tier 2, and Tier 3
5 Biologic and Medical Imaging Reagents Market Size by Type
  1. 5.1 Global Biologic and Medical Imaging Reagents Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biologic and Medical Imaging Reagents Revenue by Type (2021-2032)
  3. 5.3 Global Biologic and Medical Imaging Reagents Revenue Market Share by Type (2021-2032)
6 Biologic and Medical Imaging Reagents Market Size by Application
  1. 6.1 Global Biologic and Medical Imaging Reagents Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biologic and Medical Imaging Reagents Revenue by Application (2021-2032)
  3. 6.3 Global Biologic and Medical Imaging Reagents Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Cardinal Health
  2. 7.1.1 Cardinal Health Company Information
  3. 7.1.2 Cardinal Health Business Overview
  4. 7.1.3 Cardinal Health Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Cardinal Health Biologic and Medical Imaging Reagents Product Portfolio
  6. 7.1.5 Cardinal Health Recent Developments
  7. 7.2 Bracco
  8. 7.2.1 Bracco Company Information
  9. 7.2.2 Bracco Business Overview
  10. 7.2.3 Bracco Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bracco Biologic and Medical Imaging Reagents Product Portfolio
  12. 7.2.5 Bracco Recent Developments
  13. 7.3 Bayer HealthCare
  14. 7.3.1 Bayer HealthCare Company Information
  15. 7.3.2 Bayer HealthCare Business Overview
  16. 7.3.3 Bayer HealthCare Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bayer HealthCare Biologic and Medical Imaging Reagents Product Portfolio
  18. 7.3.5 Bayer HealthCare Recent Developments
  19. 7.4 Curium Pharma
  20. 7.4.1 Curium Pharma Company Information
  21. 7.4.2 Curium Pharma Business Overview
  22. 7.4.3 Curium Pharma Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Curium Pharma Biologic and Medical Imaging Reagents Product Portfolio
  24. 7.4.5 Curium Pharma Recent Developments
  25. 7.5 Hengrui Medicine
  26. 7.5.1 Hengrui Medicine Company Information
  27. 7.5.2 Hengrui Medicine Business Overview
  28. 7.5.3 Hengrui Medicine Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Hengrui Medicine Biologic and Medical Imaging Reagents Product Portfolio
  30. 7.5.5 Hengrui Medicine Recent Developments
  31. 7.6 GE Healthcare
  32. 7.6.1 GE Healthcare Company Information
  33. 7.6.2 GE Healthcare Business Overview
  34. 7.6.3 GE Healthcare Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GE Healthcare Biologic and Medical Imaging Reagents Product Portfolio
  36. 7.6.5 GE Healthcare Recent Developments
  37. 7.7 Lantheus Medical Imaging
  38. 7.7.1 Lantheus Medical Imaging Company Information
  39. 7.7.2 Lantheus Medical Imaging Business Overview
  40. 7.7.3 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Product Portfolio
  42. 7.7.5 Lantheus Medical Imaging Recent Developments
  43. 7.8 Novartis (AAA)
  44. 7.8.1 Novartis (AAA) Company Information
  45. 7.8.2 Novartis (AAA) Business Overview
  46. 7.8.3 Novartis (AAA) Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Novartis (AAA) Biologic and Medical Imaging Reagents Product Portfolio
  48. 7.8.5 Novartis (AAA) Recent Developments
  49. 7.9 Thermo Fisher Scientific
  50. 7.9.1 Thermo Fisher Scientific Company Information
  51. 7.9.2 Thermo Fisher Scientific Business Overview
  52. 7.9.3 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Product Portfolio
  54. 7.9.5 Thermo Fisher Scientific Recent Developments
  55. 7.10 Jubilant DraxImage
  56. 7.10.1 Jubilant DraxImage Company Information
  57. 7.10.2 Jubilant DraxImage Business Overview
  58. 7.10.3 Jubilant DraxImage Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Jubilant DraxImage Biologic and Medical Imaging Reagents Product Portfolio
  60. 7.10.5 Jubilant DraxImage Recent Developments
  61. 7.11 PerkinElmer
  62. 7.11.1 PerkinElmer Company Information
  63. 7.11.2 PerkinElmer Business Overview
  64. 7.11.3 PerkinElmer Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
  65. 7.11.4 PerkinElmer Biologic and Medical Imaging Reagents Product Portfolio
  66. 7.11.5 PerkinElmer Recent Developments
  67. 7.12 Guerbet
  68. 7.12.1 Guerbet Company Information
  69. 7.12.2 Guerbet Business Overview
  70. 7.12.3 Guerbet Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Guerbet Biologic and Medical Imaging Reagents Product Portfolio
  72. 7.12.5 Guerbet Recent Developments
  73. 7.13 Nihon Medi-Physics
  74. 7.13.1 Nihon Medi-Physics Company Information
  75. 7.13.2 Nihon Medi-Physics Business Overview
  76. 7.13.3 Nihon Medi-Physics Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Nihon Medi-Physics Biologic and Medical Imaging Reagents Product Portfolio
  78. 7.13.5 Nihon Medi-Physics Recent Developments
  79. 7.14 YRPG
  80. 7.14.1 YRPG Company Information
  81. 7.14.2 YRPG Business Overview
  82. 7.14.3 YRPG Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
  83. 7.14.4 YRPG Biologic and Medical Imaging Reagents Product Portfolio
  84. 7.14.5 YRPG Recent Developments
8 North America
  1. 8.1 North America Biologic and Medical Imaging Reagents Revenue (2021-2032)
  2. 8.2 North America Biologic and Medical Imaging Reagents Revenue by Type (2021-2032)
  3. 8.2.1 North America Biologic and Medical Imaging Reagents Revenue by Type (2021-2026)
  4. 8.2.2 North America Biologic and Medical Imaging Reagents Revenue by Type (2027-2032)
  5. 8.3 North America Biologic and Medical Imaging Reagents Revenue Share by Type (2021-2032)
  6. 8.4 North America Biologic and Medical Imaging Reagents Revenue by Application (2021-2032)
  7. 8.4.1 North America Biologic and Medical Imaging Reagents Revenue by Application (2021-2026)
  8. 8.4.2 North America Biologic and Medical Imaging Reagents Revenue by Application (2027-2032)
  9. 8.5 North America Biologic and Medical Imaging Reagents Revenue Share by Application (2021-2032)
  10. 8.6 North America Biologic and Medical Imaging Reagents Revenue by Country
  11. 8.6.1 North America Biologic and Medical Imaging Reagents Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biologic and Medical Imaging Reagents Revenue by Country (2021-2026)
  13. 8.6.3 North America Biologic and Medical Imaging Reagents Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biologic and Medical Imaging Reagents Revenue (2021-2032)
  2. 9.2 Europe Biologic and Medical Imaging Reagents Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biologic and Medical Imaging Reagents Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biologic and Medical Imaging Reagents Revenue by Type (2027-2032)
  5. 9.3 Europe Biologic and Medical Imaging Reagents Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biologic and Medical Imaging Reagents Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biologic and Medical Imaging Reagents Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biologic and Medical Imaging Reagents Revenue by Application (2027-2032)
  9. 9.5 Europe Biologic and Medical Imaging Reagents Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biologic and Medical Imaging Reagents Revenue by Country
  11. 9.6.1 Europe Biologic and Medical Imaging Reagents Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biologic and Medical Imaging Reagents Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biologic and Medical Imaging Reagents Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biologic and Medical Imaging Reagents Revenue (2021-2032)
  2. 10.2 China Biologic and Medical Imaging Reagents Revenue by Type (2021-2032)
  3. 10.2.1 China Biologic and Medical Imaging Reagents Revenue by Type (2021-2026)
  4. 10.2.2 China Biologic and Medical Imaging Reagents Revenue by Type (2027-2032)
  5. 10.3 China Biologic and Medical Imaging Reagents Revenue Share by Type (2021-2032)
  6. 10.4 China Biologic and Medical Imaging Reagents Revenue by Application (2021-2032)
  7. 10.4.1 China Biologic and Medical Imaging Reagents Revenue by Application (2021-2026)
  8. 10.4.2 China Biologic and Medical Imaging Reagents Revenue by Application (2027-2032)
  9. 10.5 China Biologic and Medical Imaging Reagents Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biologic and Medical Imaging Reagents Revenue (2021-2032)
  2. 11.2 Asia Biologic and Medical Imaging Reagents Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biologic and Medical Imaging Reagents Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biologic and Medical Imaging Reagents Revenue by Type (2027-2032)
  5. 11.3 Asia Biologic and Medical Imaging Reagents Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biologic and Medical Imaging Reagents Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biologic and Medical Imaging Reagents Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biologic and Medical Imaging Reagents Revenue by Application (2027-2032)
  9. 11.5 Asia Biologic and Medical Imaging Reagents Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biologic and Medical Imaging Reagents Revenue by Country
  11. 11.6.1 Asia Biologic and Medical Imaging Reagents Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biologic and Medical Imaging Reagents Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biologic and Medical Imaging Reagents Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biologic and Medical Imaging Reagents Revenue (2021-2032)
  2. 12.2 SAMEA Biologic and Medical Imaging Reagents Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biologic and Medical Imaging Reagents Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biologic and Medical Imaging Reagents Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biologic and Medical Imaging Reagents Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biologic and Medical Imaging Reagents Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biologic and Medical Imaging Reagents Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biologic and Medical Imaging Reagents Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biologic and Medical Imaging Reagents Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biologic and Medical Imaging Reagents Revenue by Country
  11. 12.6.1 SAMEA Biologic and Medical Imaging Reagents Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biologic and Medical Imaging Reagents Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biologic and Medical Imaging Reagents Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst